Letter to the editor regarding the paper by Loquai C et al. 'Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients'

Autor: Elizabeth Fabre, Benoit Blanchet, Audrey Thomas-Schoemann

Publikováno v: European journal of cancer (Oxford, England : 1990). 85

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7458ca563c26ed3d06b1a340b56775a8
https://pubmed.ncbi.nlm.nih.gov/27984769

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.

Autor: Koch EAT; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany., Petzold A; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany., Wessely A; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany., Dippel E; Department of Dermatology, Ludwigshafen Medical Center, 67059, Ludwigshafen, Germany., Eckstein M; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.; Institute of Pathology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany., Gesierich A; Department of Dermatology, University Hospital Würzburg, 97080, Würzburg, Germany., Gutzmer R; Skin Cancer Center Minden, Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University, Bochum Campus Minden, 32423, Minden, Germany., Hassel JC; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, 69120, Heidelberg, Germany., Knorr H; Department of Ophthalmology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany., Kreuzberg N; Department of Dermatology and Venereology, Skin Cancer Center at the Center of Integrated Oncology (CIO) Köln Bonn, University Hospital of Cologne, 50937, Cologne, Germany., Leiter U; Department of Dermatology, Center for Dermatooncology, University Hospital Tübingen, 72056, Tübingen, Germany., Loquai C; Department of Dermatology, University Medical Center Mainz, 55131, Mainz, Germany., Meier F; Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases & Department of Dermatology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany., Meissner M; Department of Dermatology, Venereology and Allergology, Goethe University, 60590, Frankfurt am Main, Germany., Mohr P; Department of Dermatology, Elbeklinikum, 21614, Buxtehude, Germany., Pföhler C; Department of Dermatology, Saarland University Medical School, 66421, Homburg/Saar, Germany., Rahimi F; Department of Dermatology and Allergy, Munich University Hospital (LMU), 81377, Munich, Germany., Schadendorf D; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, and German Cancer Consortium (DKTK), partner site, Essen/Düsseldorf, Germany, 45147., Schlaak M; Department of Dermatology, Venerology and Allergology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Thoms KM; Department of Dermatology, University Medical Center Goettingen, 37075, Goettingen, Germany., Ugurel S; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, and German Cancer Consortium (DKTK), partner site, Essen/Düsseldorf, Germany, 45147., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, and DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Weichenthal M; Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, 24105, Kiel, Germany., Schuler-Thurner B; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany., Berking C; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany., Heppt MV; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany. markus.heppt@uk-erlangen.de.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054, Erlangen, Germany. markus.heppt@uk-erlangen.de.; Deutsches Zentrum Immuntherapie (DZI), Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany. markus.heppt@uk-erlangen.de.; Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany. markus.heppt@uk-erlangen.de.

Publikováno v: Frontiers of medicine [Front Med] 2023 Oct; Vol. 17 (5), pp. 878-888. Date of Electronic Publication: 2023 Jul 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.

Autor: Wang Y; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany., Ertl C; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.; SERIO Registry, Munich, Germany., Schmitt C; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany., Hammann L; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany., Kramer R; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC-ER-EMN), Erlangen, Germany., Grabmaier U; Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany., Schöberl F; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Vertigo and Balance Disorders (DSGZ), LMU University Hospital, LMU Munich, Munich, Germany., Anz D; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany., Piseddu I; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany., Pesch G; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany., Vera J; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC-ER-EMN), Erlangen, Germany., Froehlich W; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany., Weckbach L; Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany., Tomsitz D; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany., Loquai C; Department of Dermatology, Klinikum Bremen-Ost, Gesundheit Nord gGmbH, Bremen, Germany., Zimmer L; Department of Dermatology, University Hospital Essen & German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, & National Center for Tumor Diseases (NCT)-West, Campus Essen, & Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Mangana J; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Mühlenkreiskliniken (MKK), Ruhr University Bochum, Minden, Germany., Klespe KC; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Stege H; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Meiss F; Faculty of Medicine, Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany., Thoms KM; Department of Dermatology, University Medical Center Goettingen, Georg-August-University, Goettingen, Germany., Terheyden P; Department of Dermatology, University of Lübeck, Lübeck, Germany., Bröckelmann PJ; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., French LE; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States., Heinzerling L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.; SERIO Registry, Munich, Germany.; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC-ER-EMN), Erlangen, Germany.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2024 Jun 10; Vol. 11, pp. 1408586. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).

Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.

Autor: Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. kckaehler@yahoo.de., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Medical School, Bochum, Germany., Angela Y; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Medical School, Bochum, Germany., Livingstone E; Department of Dermatology, University Hospital Essen, Essen, Germany., Lodde G; Department of Dermatology, University Hospital Essen, Essen, Germany., Meiss F; Department of Dermatology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Rafei-Shamsabadi DA; Department of Dermatology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Weyer-Fahlbusch SS; Department of Dermatology, Dortmund, Germany., Nashan D; Department of Dermatology, Dortmund, Germany., Loquai C; Department of Dermatology, Klinikum Bremen-Ost, Gesundheitnord gGmbH, Bremen, Germany., Hassel JC; Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University, NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Sachse MMM; Department of Dermatology, Bremerhaven, Germany., Maul LV; Department of Dermatology, University Hospital Basel, Basel, Switzerland.; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Heinzerling L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany., Heppt MV; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany., Colapietro C; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany., Rusch J; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Blome C; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 May 14; Vol. 150 (5), pp. 252. Date of Electronic Publication: 2024 May 14.